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Abstract
Background: Pseudogenes are an integral component of the human genome. Little attention, however,
has so far been paid to the phenomenon that some pseudogenes are transcriptionally active. Recently, we
demonstrated that the human ortholog of the rodent testis-specific ATP-binding cassette (ABC)
transporter Abca17 is a ubiquitously transcribed pseudogene (ABCA17P). The aim of the present study was
to establish a complete inventory of all ABC transporter pseudogenes in the human genome and to identify
transcriptionally active ABC transporter pseudogenes. Moreover, we tested the hypothesis that a
regulatory interdependency exists between ABC transporter pseudogenes and their parental protein
coding equivalents.
Results: Systematic bioinformatic analysis revealed the existence of 22 ABC transporter pseudogenes
within the human genome. We identified two clusters on chromosomes 15 and 16, respectively, which
harbor almost half of all pseudogenes (n = 10). Available information from EST and mRNA databases and
RT-PCR expression profiling indicate that a large portion of the ABC transporter pseudogenes (45%, n =
10) are transcriptionally active and some of them are expressed as alternative splice variants. We
demonstrate that both pseudogenes of the pseudoxanthoma elasticum gene ABCC6, ABCC6P1 and
ABCC6P2, are transcribed. ABCC6P1 and ABCC6 possess near-identical promoter sequences and their
tissue-specific expression profiles are strikingly similar raising the possibility that they form a gene-
pseudogene dual transcription unit. Intriguingly, targeted knockdown of the transcribed pseudogene
ABCC6P1 resulted in a significant reduction of ABCC6 mRNA expression levels.
Conclusion: The human genome contains a surprisingly small number of ABC transporter pseudogenes
relative to other known gene families. They are unevenly distributed across the chromosomes.
Importantly, a significant portion of the ABC transporter pseudogenes is transcriptionally active. The
downregulation of ABCC6 mRNA levels by targeted suppression of the expression of its pseudogene
ABCC6P1 provides evidence, for the first time, for a regulatory interdependence of a transcribed
pseudogene and its protein coding counterpart in the human genome.
Published: 11 April 2008
BMC Genomics 2008, 9:165 doi:10.1186/1471-2164-9-165
Received: 17 December 2007
Accepted: 11 April 2008
This article is available from: http://www.biomedcentral.com/1471-2164/9/165
© 2008 Piehler et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 13
(page number not for citation purposes)
BMC Genomics 2008, 9:165 http://www.biomedcentral.com/1471-2164/9/165Background
Human ATP-binding cassette (ABC) transporters form a
large family of structurally highly related membrane
transport proteins. Based on sequence similarities, the
human ABC transporter family is categorized into seven
subfamilies, denoted ABC A-G, and consists of 48 mem-
bers. ABC transporters translocate a wide range of sub-
strates across cellular membranes, e.g. lipids, sugars,
peptides, ions and xenobiotics such as anticancer drugs
[1,2]. Defective ABC transporters cause monogenetic dis-
orders and contribute to the development of complex dis-
eases [3]. The physiological importance of ABC proteins is
highlighted by the fact that mutations in 14 human ABC
transporter genes have thus far been linked to a spectrum
of unrelated hereditary diseases [2].
Beside protein coding genes for ABC transporters, it has
been shown that the human genome contains several ABC
transporter pseudogenes [4]. However, the exact number
of ABC transporter pseudogenes present in the human
genome is still unclear. Generally, pseudogenes are
defined as non-functional sequences that are present in
the genome with high similarity to one or more paralo-
gous genes. This lack of function is a result of either failure
of transcription or translation, or production of a protein
that differs in function from the protein encoded by the
functional gene [5]. Pseudogenes are thought to arise
either by gene duplication and subsequent degeneration
of the duplicated gene or by retroposition of a reversely
transcribed mRNA of the paralogous gene into the
genome. The latter are intronless and referred to as "proc-
essed" pseudogenes [6].
During the past years, we and others provided evidence
for the existence of ABC transporter pseudogenes which
are transcriptionally active [7-9]. For example, we recently
demonstrated that the human ortholog of the rodent tes-
tis-specific ABC transporter Abca17, a protein coding
gene, is a pseudogene (ABCA17P) which is transcribed
into up to 20 alternative splice variants [9]. These results
raise the intriguing possibility that ABC transporter pseu-
dogene transcripts may serve biological functions other
than providing the genetic blueprints for protein biosyn-
thesis.
In this study, we applied a comprehensive bioinformatic
approach to identify all ABC transporter pseudogenes in
the human genome and systematically searched for evi-
dence of transcribed pseudogenes. We identified a total of
22 pseudogenes within the ABC transporter family with a
significant subfraction (n = 10) exhibiting transcriptional
activity. We find evidence for transcription of the two pre-
viously known ABCC6 pseudogenes ABCC6P1 and
ABCC6P2, respectively, and report their gene structures.
Moreover, we demonstrate, for the first time, a regulatory
interdependency between ABCC6P1, and its translated
counterpart, the pseudoxanthoma elasticum gene ABCC6.
Results
The human genome contains 22 ABC transporter 
pseudogenes
To identify homologs of human ABC transporters, we per-
formed a genome-wide search based on the sequences of
the known 48 human and the five murine ABC trans-
porter genes, for which no orthologous counterpart as yet
have been documented in the human genome (Abca14-
Abca17,Abcg3). The strategy relied on a BLAST homology
search (cut-off E-value: 0.001) in which the ABC trans-
porter nucleotide reference sequences were used as query
sequences. These were compared with a version of the
human genome (assembly March 2006, NCBI Build 36,
hg18) in which the known exons of the ABC transporter
query sequences were masked. Our search algorithm
resulted in 3,322,841 primary hits. Detailed sequence
analyses revealed that a surprisingly large fraction (33/48,
69%) of the known human ABC transporter cDNAs con-
tain repetitive elements (Additional File 1). We then
excluded all hits that were attributable to repetitive ele-
ments and assorted the remaining hits (n = 174) accord-
ing to their chromosomal position. Neighbouring hits
were merged to a single pseudogene candidate when they
(i) displayed highest similarity to the same protein coding
ABC transporter gene, (ii) were localized at a distance <
0.1 Mb apart from each other and (iii) were oriented in
the same 5'→ 3' order as the matching protein coding ABC
transporter nucleotide sequence. In those cases where a
neighbouring hit was absent, a flanking 0.1 Mb genomic
region was aligned with the respective ABC transporter
nucleotide sequence using the more rigorous alignment
tool "matcher" from the EMBOSS package. This approach
warrants that more distantly related ABC transporter pseu-
dogenes are overlooked at a minimal rate. Hits with >
70% identity across at least one complete exon of the
respective ABC transporter nucleotide sequence, were
considered homologous and evaluated by the above crite-
ria (i-iii). Merged hits were regarded as pseudogenes when
they encompassed at least two homologous exons of the
protein-coding gene and had defective reading frames
which preclude translation into polypeptides that meet
the minimum structural requirements for functional ABC
full-size or half-size transporters. Using this strategy, we
identified a total of 22 loci in the human genome that rep-
resent degenerated copies of protein coding ABC trans-
porter genes. They show > 70% similarity to the cDNA of
their protein coding counterparts across a range of 159 –
3754 bp and contain the homologs of two up to 19 exons
of the respective parental gene. The ABC transporter pseu-
dogenes we identified could be assigned to all seven sub-
families, ABC A- ABC G (Table 1). We found that, within
the genome, they are routinely present on chromosomesPage 2 of 13
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3, 4, 7, 10, 14, 16, 21) with the exception of chrs. 15 and
22, respectively, from which protein coding ABC trans-
porter genes are absent (Figure 1). Of note, half of the 22
ABC transporter pseudogenes are localized on chromo-
somes 15 (n = 4) and 16 (n = 7), respectively. Intriguingly,
the seven pseudogenes on the short arm of chr. 16
(16p11.2-p13.3) are clustered within a segment of 30 Mb
in the order tel-ABCA17P – ABCC6P2 – ABCC6P1 –
ABCA14P – ABCA15P1 – ABCA15P2 – ABCD1P3-cer.
A total of 10 ABC transporter pseudogenes (45%) were
intronless, directly flanked by repetitive sequences (as
identified with the RepeatMasker track, UCSC Genome
Browser), and most of them (n = 8) also exhibited
poly(A)-tails. These structural features are diagnostic of
processed pseudogenes [10] strongly suggesting that they
originated from retrotransposed transcripts of ancestral
functional ABC transporter genes (Table 1).
A significant portion of human ABC transporter 
pseudogenes are transcriptionally active
To assess which of the identified human ABC transporter
pseudogenes are transcribed, we analyzed all 22 pseudog-
enic ABC transporter loci for homologies with EST or
mRNA sequences using the UCSC Genome Browser.
Using this approach 101 EST and/or mRNA sequences
were identified that exhibited best hits (> 99% overall
identity) with 10 of the 22 human ABC transporter pseu-
dogenes. These sequences displayed higher sequence
identity to their corresponding pseudogene locus than to
any other location in the human genome. This indicates
that a significant portion (45%) of the human ABC trans-
porter pseudogenes is transcriptionally active (Table 1).
Among these, n = 5 (50%) are processed pseudogenes.
Consistent with our in-silico results, RT-PCR expression
analysis of all ABC transporter pseudogene transcripts that
span at least two exons demonstrated that the pseudo-
genes ABCA10P, ABCA15P2, ABCA17P, ABCC2P,
ABCC6P1, ABCC6P2 and ABCG2P2 are in fact transcribed
(Figure 2). Interestingly, we identified alternatively
spliced transcripts in three out of the 10 transcribed pseu-
dogenes (ABCA10P, ABCA15P2, ABCA17P).
Chromosomal distribution of human ABC transporter pseudogenes and protein-coding genesFigure 1
Chromosomal distribution of human ABC transporter pseudogenes and protein-coding genes. Pseudogenes of 
the human ABC transporter family are widely distributed throughout the human genome. Shown are the chromosomal locali-
zations (colored arrows) of ABC transporter pseudogenes (right-hand side of each chromosome) and their parental protein-
coding genes (left) in the human genome. Pairs of parental genes and pseudogenes are represented by the same arrow color 
code. Transcribed pseudogenes are green shaded. A close-up view of the ABC transporter pseudogene cluster (30 Mb) on 
chromosome 16p is shown at the bottom. Arrows indicate the 5'-> 3' orientation of the pseudogenes on chr. 16p and dis-
tances between adjacent pseudogenes are detailed (Mb). ABCA14P, ABCA15P1 and ABCA15P2, respectively, represent pseudo-
genes for which functional counterparts have only been reported in rodents (Abca14, Abca15). The ideogram was generated 
using the ColoredChromosomes software [41].Page 3 of 13
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pseudogenes ABCC6P1 and ABCC6P2 in various human 
tissues
Two pseudogenes, ABCC6P1 and ABCC6P2, have been
reported for the pseudoxanthoma elasticum gene ABCC6,
a member of the ABC C-subfamily [7]. They are located
2.3 Mb centromeric (ABCC6P1) and 1.3 Mb (ABCC6P2)
telomeric, respectively, of the protein coding ABCC6 gene
(Figure 3). When we performed a detailed bioinformatic
analysis of both pseudogenes, we retrieved a poly(A)-con-
taining 2.7 kb mRNA from the GenBank NCBI database
which had been isolated from human liver cells during
the course of the Mammalian Gene Collection Program
[11]. The transcript [GenBank: BC075833] exhibits per-
fect homology with the 9 putative exons of ABCC6P1 indi-
cating that this pseudogene is transcriptionally active.
Comparison of the genomic sequence and the 2.7 kb tran-
script revealed that the ABCC6P1 gene consists of 10
exons (Figure 3). The ABCC6P1 intron sizes range from
0.1 to 5.2 kb. Exons 1–9 have perfect or near perfect iden-
tity (98.3%–100%) to the corresponding exons of the
parental gene ABCC6. In contrast, the final exon (exon
Table 1: ABC transporter pseudogenes in the human genome
Parental gene ψ-gene symbol Chromosomal 
band
Chromosomal 
position*
Processed Evidence for 
transcription
Alternatively 
spliced transcripts
Accession 
number**
ABCA10 ABCA10P 
(ABCA11)
4p16.3 408750–411669 + + 3 AK024359
ABCA3/Abca17 ABCA17P 16p13.3 2330924–
2416701
- + 20 DQ266102
ABCB4 ABCB4P 4q32.1 158955613–
158956084
+ - -
ABCB10 ABCB10P1 15q11.2 20240777–
20244535
+ + nd DB511925
ABCB10P2 15q13.1 26321621–
26325378
+ - -
ABCB10P3 15q13.1 26552813–
26550744
+ + nd BP260092
ABCC2 ABCC2P 
(ABCC13)
21q11.2 14568083–
14593875
- + - AY344117
ABCC6 ABCC6P1 16p12.3 18490076–
18511541
- + - BC075833
ABCC6P2 16p13.11 14822152–
14826050
- + - BC015978
ABCD1 ABCD1P1 2p11.1 91392363–
91396515
- - -
ABCD1P2 10p11.1 38934556–
38938703
- - -
ABCD1P3 16p11.2 32392919–
32397074
- - -
ABCD1P4 22q11.1 15248418–
15252575
- - -
ABCE1 ABCE1P1 1q31.2 190481983–
190483713
+ - -
ABCE1P2 7p15.3 23566974–
23570537
+ + nd AY962469
ABCF2 ABCF2P1 3p11.2 88448934–
88451415
+ - -
ABCF2P2 7q11.2 71206102–
71208540
- - -
ABCG2 ABCG2P1 14q24.3 76895512–
76896054
+ - -
ABCG2P2 15q23 67101380–
67103614
+ + nd CR610432
Abca14 ABCA14P 16p12.2 21210041–
21219286
- - -
Abca15 ABCA15P1 16p12.2 21257276–
21257846
- - -
ABCA15P2 16p12.1 21857685–
21863768
- + 2 DR731461
*Chromosome positions refer to the human genome NCBI Build 36 (hg18, assembly March 2006).
**Accession numbers refer to identified EST or mRNA sequences representing transcribed pseudogenesPage 4 of 13
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the observed sequence disparity in exon 10, the transcripts
of ABCC6P1 and ABCC6 can be reliably distinguished by
RT-PCR. Moreover, it allows selective targeting of the
pseudogene transcript using RNA interference strategies.
We also found in silico evidence for transcription of the
second ABCC6 pseudogene, ABCC6P2. Consistent with
this, our RT-PCR experiments using pooled mRNA from
20 human tissues confirmed expression of this pseudog-
ene (Figure 2). ABCC6P2 is composed of four exons
whose lengths vary between 59–183 bp which exhibit
highest sequence similarity (98–100%) with the corre-
sponding exons of its parental gene. Intron sizes of
ABCC6P2 range from 0.1 to 1.7 kb. Interestingly, Gen-
bank mRNA database searches revealed a 0.7 kb poly(A)-
tail transcript which displays perfect identity with
ABCC6P2 exons 1 and 2 plus additional 504 bp of the sec-
ond intron (Figure 3). This transcript has been independ-
ently identified in the Mammalian Gene Collection
Program [11] from the kidney [GenBank: BC015978].
We next tested whether and to which degree regulatory
interdependencies exist between ABCC6 and ABCC6P1.
For this, we performed expression profiling of both genes
in various human tissues by real-time PCR. Expression
levels were normalized to the expression of the house-
keeping gene β-actin. We observed a similar gene expres-
sion pattern for ABCC6 and ABCC6P1 with highest
expression levels in liver and kidney (Figure 4A, B). In
most tissues ABCC6 mRNA levels were moderately higher
(on average 2–4 fold) than those of ABCC6P1, however,
ABCC6P1 was the predominant transcript in bone mar-
row and fetal brain (Figure 4C). Similar results were
obtained when the expression levels were normalized to
cyclophilin B, another housekeeping gene (data not
shown).
The striking co-expression of the ABCC6 and ABCC6P1
raises the possibility that transcription of both genes is
controlled by similar regulatory elements. When we com-
pared the 5' regulatory region sequences of both genes, we
found that they share an overall sequence similarity of
98.9% within the first 2.5 kb upstream of the start codon,
the region that contains the putative core promoters
(Additional File 2). Of note, 68 out of the 72 potential
transcription factor binding sites, which we identified
within the predicted ABCC6P1 promoter region, are fully
intact. In particular, an NF-κB consensus binding
sequence (pos. -233 bp), known to confer high-level
ABCC6 expression in HepG2 hepatoma cells [12], is com-
pletely conserved in the putative ABCC6P1 promoter
region. Three binding sites, a glucocorticoid response ele-
ment (GR, pos. -2116 bp), an octamer binding factor (oct-
1, pos. -1746 bp) and a GATA-3 consensus site (pos. -
1269 bp), respectively, show single base exchanges. In
addition, a USF binding site (pos. -622 bp) exhibits a non-
amer-deletion which disrupts the respective consensus
Expression of human ABC transporter pseudogene RNAsFigure 2
Expression of human ABC transporter pseudogene 
RNAs. RT-PCR expression profiling demonstrating that the 
ABC transporter pseudogenes ABCA10P, ABCA15P2, 
ABCA17P, ABCC2P, ABCC6P1, ABCC6P2 and ABCG2P2, respec-
tively, are transcribed as predicted by our in silico results.RT-
PCR was performed using human cDNA from pooled tissues. 
Note that ABCA10P, ABCA15P2, and ABCA17P are expressed 
as alternatively spliced transcript variants (as confirmed by 
sequence analysis) (arrows).Page 5 of 13
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five novel transcription factor binding sites (SRY -2381
bp, C/EBPb -1223 bp, GATA-2 -1124 bp, AML-2 -464 bp,
C/EBP -316 bp) in the predicted ABCC6P1 promoter.
Comparison of the ABCC6 promoter sequence with the
ABCC6P2 5' UTR revealed an even higher degree of
homology (99.6%) than that observed for ABCC6P1. A
total of 71 out of 72 transcription factor binding sites were
fully conserved strongly suggesting that the ABCC6P2
expression pattern is highly similar to that of ABCC6 and
ABCC6P1, respectively. We were unable, however, to
quantitate ABCC6P2 expression levels by real-time PCR
because the small size of the transcript and its exceedingly
high sequence homology with ABCC6 and ABCC6P1
hampered specific detection of ABCC6P2 mRNA.
Targeted knockdown of the pseudogene ABCC6P1 results 
in downregulation of ABCC6 mRNA expression
The ABCC6/ABCC6P1 gene-pseudogene pair is unique in
that (i) both components exhibit similar expression pat-
terns, (ii) share the extensive similarity of their (putative)
promoter regions and (iii) are positioned in close spatial
proximity on chr. 16p12. The combination of these fea-
tures raises the question as to whether regulatory interde-
pendencies exists between ABCC6P1 and its paralog
Genomic organization of ABCC6P1 and ABCC6P2, two transcribed pseudogenes of ABCC6Figure 3
Genomic organization of ABCC6P1 and ABCC6P2, two transcribed pseudogenes of ABCC6. The pseudogenes 
ABCC6P1 and ABCC6P2 flank their parental gene ABCC6 at a distance of 2.3 Mb and 1.3 Mb, respectively, on chromosome 
16p13. Arrows indicate the direction of transcription. The structures of the ABCC6P1 and ABCC6P2 genes and their transcripts 
are illustrated in higher magnification. Exons are represented by black boxes and numbered in 5' to 3' order. Similarities (%) of 
pseudogene exons with their corresponding ABCC6 exons are shown in parenthesis. The terminal non-homologous exon of 
ABCC6P1 is shaded blue. The red box highlights the last exon of ABCC6P2 which contains a part of intron 2. Metric scale bars 
are indicated for orientation.Page 6 of 13
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ABCC6 and its transcribed pseudogene ABCC6P1 are co-expressed in a variety of human tissuesFigure 4
ABCC6 and its transcribed pseudogene ABCC6P1 are co-expressed in a variety of human tissues. Relative tran-
scription levels of ABCC6 (A) and ABCC6P1 (B) were determined in 20 different human tissues by real-time RT-PCR relative to 
those of the housekeeping gene β-actin. Highest expression of both ABCC6 and ABCC6P1 was observed in adult liver (reference 
= 100%), kidney and fetal liver. (C) ABCC6/ABCC6P1 transcript ratios. Note that ABCC6 and ABCC6P1 are co-expressed in all 
tissues investigated with the ABCC6 expression levels being on average 2–4 times higher than those of ABCC6P1. Ratios are 
shown in a logarithmic scale (base 2).
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ing of ABCC6P1 has an effect on ABCC6 expression. For
this, a siRNA-mediated gene knockdown approach target-
ing the non-homologous exon 10 of ABCC6P1 was used
which allows selective silencing of ABCC6P1 but not
ABCC6. Among several exon10 specific siRNAs, we
selected the one by which the most efficient gene silencing
could be obtained in HepG2 liver cells. Knockdown
effects were normalized to the housekeeping genes β-actin
and cyclophilin B, respectively. Using this approach, an
average 69% (SD 4%, 95%-CI: 65–73%) knockdown of
the ABCC6P1 pseudogene was achieved in six independ-
ent experiments (Figure 5, lane 3). Importantly, knock-
down of ABCC6P1 led to a significant reduction of ABCC6
mRNA expression. The residual expression of ABCC6 was
84% (SD 7%, p = 0.003, 95%-CI: 76–91%), when nor-
malized to β-actin, and 82% (SD 11%, p = 0.01, 95%-CI:
72–93%) relative to cyclophilin B, respectively (Figure 5,
lane 4). No significant changes in ABCC6 or ABCC6P1
expression levels were observed in HepG2 cells when
unspecific siRNA were used or lipid transfection agent
alone were used (negative controls, data not shown). In
contrast, GAPDH-specific siRNA (positive control)
showed an 89% (95%-CI: 87–97%) knockdown relative
to β-actin and cyclophilin B (Figure 5, lane 2). Similarity
searches using the ABCC6P1 siRNA target sequence (21
bp) as a bait consistently showed mismatches > 5 bp
throughout the entire promoter region and all exons and
introns of ABCC6. Therefore, the siRNA mediated sup-
pression of ABCC6 cannot be attributed to "co-targeting"
of a common sequence motif in both genes. Our finding
that silencing of ABCC6P1 has a suppressive effect on
ABCC6 thus suggest that the expression of ABCC6P1 and
its parental gene are interdependent.
Discussion
In our study, we report the existence of 22 human ABC
transporter pseudogenes. The total number of pseudo-
genes in the human genome has been estimated to
~20000 [13-15], whereas the predicted number of protein
coding genes amounts to 20000 – 25000 [16]. This esti-
mation indicates a genome-wide gene/pseudogene ratio
of app. 1:1. Given the existence of 48 functional human
ABC transporters, the ABC transporter genes/pseudogene
ratio is app. 2:1. Thus, the number of ABC transporter
pseudogenes in the human genome is significantly lower
than the expected average frequency of pseudogenes
within currently identified gene-pseudogene families [17-
19].
Our results indicate that the pseudogenes of the ABC
transporter family are distributed unevenly across the
chromosomes. Approximately one-half of the ABC trans-
porter pseudogenes (n = 11) is dispersed across several
chromosomes, whereas the other half is clustered on chr.
15 and 16, respectively. Of these, seven pseudogenes are
located on the short arm of chr. 16 within a segment of 30
Mb (16p11.2-p13.3) and three processed (intronless)
pseudogenes are clustered on the long arm of chr. 15. The
ABC transporter pseudogene cluster on chr. 16p consists
of three protein-coding ABC transporter genes, six dupli-
cated pseudogenes and one processed pseudogene. Clus-
tering of pseudogenes has been observed for other gene
families in various vertebrates including the group of cyto-
chrome P450 enzymes, α-globin, and the variable gene
segments of the immunoglobulin heavy and light genes,
respectively [17,20,21]. These gene clusters are usually
composed of both protein coding genes and pseudogenes
from the same gene family, which likely reflects the fact
that pseudogenization is a mechanism that is highly asso-
ciated with gene duplication events. The close spatial
proximity of genes and pseudogenes suggests that the
gene duplications are more recent evolutionary events
because dispersion across the genome has not yet
occurred. In light of this, it is reasonable to assume that
the ABC transporter pseudogenes located on chr. 15 and
16 are indeed the result of gene duplication and subse-
quent pseudogenization of the previously functional ABC
transporter genes. Of note, the rodent genome contains
Silencing of the transcribed pseudogene ABCC6P1 downregu-lat s mRNA levels of ABCC6Figure 5
Silencing of the transcribed pseudogene ABCC6P1 
downregulates mRNA levels of ABCC6. Targeted 
siRNA-mediated inhibition of ABCC6P1 expression in HepG2 
cells results in significant downregulation (69%, 95%-CI: 65–
73%) of the pseudogene transcript levels (lane 3). mRNA lev-
els are normalized to β-actin (yellow bars) and cyclophilin B 
(blue bars). ABCC6P1 silencing is associated with a reduction 
of ABCC6 mRNA expression (84%, p = 0.003, 95%-CI: 76–
91%, yellow bar; 82%, p = 0.01, 95%-CI: 72–93%, blue bar, 
lane 4). A positive control (knock-down of GAPDH) is shown 
(lane 2). Data were obtained from six independent experi-
ments. The relative expression levels before knock-down 
experiments were set to 100% (lane 1).Page 8 of 13
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[23]. It is thus conceivable that the human orthologs of
these intact genes were functional for a certain time period
after duplication before they ultimately became disabled.
As for ABCC6P1 and ABCC6P2, the other two duplicated
pseudogenes on chr 16, it remains unclear whether they
arose by complete duplication of the parental ABCC6
gene and thus may have temporarily maintained their
function or whether only fragments of this gene were
duplicated ab ovo.
Unlike in the case of non-processed pseudogenes, the
chromosomal distribution of processed pseudogenes gen-
erally appears to be random with the number of pseudo-
genes per chromosome being proportional to
chromosomal length [15]. This is consistent with the view
that processed pseudogenes originate from nondirected
retrotransposition of preexisting transcripts. Interestingly,
the pseudogene cluster on chr. 15 contains three proc-
essed pseudogenes (ABCB10P1-3) which are localized in
close proximity to each other (their parental gene ABCB10
is located on chr. 1). Because it is unlikely that the
ABCB10P cluster is the result of three independent retro-
transposition events targeting one and the same chromo-
somal segment, two of the three ABCB10 pseudogenes
most likely arose by gene duplication. The homology
analyses, which we conducted, indeed suggest that
ABCB10P1 may have originated from ABCB10 by a retro-
transposition process. Intriguingly, they also strongly sup-
port the view that ABCB10P2 arose by duplication of
ABCB10P1 and ABCB10P3 is the result of the duplication
of ABCB10P2 (Additional File 3). Because ABCB10P2 and
ABCB10P3 most likely arose by duplication of an already
disabled processed pseudogene, it is reasonable to assume
that these pseudogenes never had the capacity to encode
proteins. To our knowledge, the ABCB10P cluster thus
represents the first example of the multiplication of a
processed pseudogene in the human genome.
Importantly, we obtained bioinformatic evidence indicat-
ing that app. one-half (45%) of the human ABC trans-
porter pseudogenes are transcriptionally active.
Consistent with this, our RT-PCR based survey demon-
strated that at least 7 out of the predicted transcriptionally
active pseudogenes were in fact transcribed. Little atten-
tion has so far been paid to the phenomenon of pseudog-
ene transcription [6] owing to the fact that pseudogenes
are generally thought to be functionless genomic relics.
However, this view is challenged by some recent studies.
For example, a comprehensive study focussing on tran-
scription of processed pseudogenes in the human genome
revealed that a subfraction of app. 5% of all processed
pseudogenes identified are transcribed [24]. Moreover,
analysis of pseudogene transcription on human chr. 22
using a combined bioinformatic/microarray approach
demonstrated that up to 20% of the pseudogenes identi-
fied on this chromosome are transcriptionally active [25].
The surprisingly high proportion of potentially tran-
scribed pseudogenes questions the traditional view of
pseudogenes and raises the intriguing possibility that
transcribed pseudogenes may serve defined biological
functions in the genome. The concept is supported by two
recent studies which provide experimental evidence for
pseudogene function. Korneev et al. reported direct inter-
ference of a gene and its transcribed pseudogene by dem-
onstrating that the antisense pseudogene anti-NOS,
whose transcript forms stable RNA-RNA complexes with
the mRNA of nNOS, inhibits protein expression of its
parental gene [26]. Another study highlights the fact that
pseudogene expression can exert a biological function
that is unrelated to its ancestral gene as evidenced for the
human Xist noncoding RNA gene, which initiates X chro-
mosome inactivation and has evolved in eutherians by
pseudogenization of the protein coding gene Lnx3 [27].
To test whether and to which degree regulatory interde-
pendencies exist between transcribed ABC transporter
pseudogenes and their protein coding counterparts, we
selected the pseudoxanthoma elasticum gene, ABCC6,
and its transcribed pseudogene ABCC6P1. This gene-pseu-
dogene pair appeared to be an ideal candidate for interfer-
ence studies because ABCC6 and ABCC6P1 exhibit near
perfect sequence homology in their transcripts but, at the
same time, can still be discriminated by RT-PCR due to
non-homology disparity in the final exon (exon 10) of
ABCC6P1. Moreover, this sequence disparity allowed the
selective targeting of the pseudogene transcript using an
siRNA approach. mRNA expression profiling of ABCC6
and ABCC6P1 revealed that both genes are consistently
co-expressed in a wide range of human tissues with pre-
dominant expression in adult liver, kidney and fetal liver
(in this order). The tissue expression pattern we observed
for ABCC6 is in keeping with a recent genome-wide gene
expression study involving 79 human tissues [28]. Regret-
tably, this work does not include expression data on the
pseudogene ABCC6P1. Our finding that ABCC6 and
ABCC6P1 share near-perfect identity in their respective
core promoter regions together with the observed co-
expression pattern strongly suggests that the expression of
the gene-pseudogene pair is governed by the same tran-
scription factor machinery.
Intriguingly, we found that selective knockdown of
ABCC6P1 leads to a reduction of ABCC6 mRNA expres-
sion suggesting that the expression of ABCC6P1 and its
parental gene are interdependent. At this point, the regu-
latory mechanisms which underlie the observed gene-
pseudogene interference remain speculative. It is well
established that mRNA stability and degradation signifi-
cantly depends on specific cis-acting elements in mRNAPage 9 of 13
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can be found both in the UTR and the coding regions of
mRNA are attacked by trans-acting machineries facilitating
mRNA decay [29]. Transcripts from distinct genes which
exhibit extensive sequence homology (as in the case of
gene-pseudogene pairs) and thus contain identical desta-
bilizing cis-elements may compete for such trans-acting
elements. It is thus conceivable that the ABCC6 and the
ABCC6P1 transcripts due to their high sequence similarity
and their topological proximity compete for the same cel-
lular RNA degradation route. As a consequence, lower
abundance in ABCC6P1 transcripts may thus lead to an
increased ABCC6 mRNA degradation rate. It will be chal-
lenging to characterize in more detail the molecular inter-
dependency between the ABCC6 and ABCC6P1
transcription units. Knowledge of ABCC6/ABCC6P1 regu-
latory interaction may be of potential relevance to clinical
medicine because ABCC6 is the underlying gene defect in
the syndrome pseudoxanthoma elasticum.
Conclusion
In this study, we established the existence of 22 ABC trans-
porter pseudogenes in the human genome. Combined
bioinformatic and experimental results indicate that a sig-
nificant portion of these pseudogenes (45%) are tran-
scribed and we provide evidence, for the first time, for
expression of alternatively spliced pseudogene RNAs in
the human genome. Moreover, we show that ABCC6P1,
one of the pseudogenes of the pseudoxanthoma elasticum
gene ABCC6, is co-expressed with ABCC6 in a variety of
tissues and that knockdown of ABCC6P1 expression
impacts the expression of ABCC6 strongly suggesting a
regulatory interdependence between ABCC6P1 and its
ancestral gene. The emerging concept of pseudogene tran-
scription and functionality has recently found its reflec-
tion in the redefinition of pseudogenes as "genomic
sequences that arise from functional genes but that cannot
encode the same type of functional product [...] as the
original gene" [30]. Accordingly, a subclassification into
(i) 'ghost' pseudogenes with some intermediate function-
ality, i.e. similar to a functional gene and transcribed and/
or functional, and (ii) 'dead' pseudogenes that lack any
functionality has recently been proposed. Our results pre-
sented here strongly support this novel differentiated view
on the biology of pseudogenes.
Methods
Bioinformatic identification of human ABC transporter 
pseudogenes
To identify all ABC transporter pseudogenes in the human
genome, we retrieved the complete sequence of the
human genome [31] chromosome-wise from the UCSC
Genome Browser (assembly March 2006, NCBI Build 36,
hg18) [32,33].
A stand-alone version of the program MaskSeq was used
to mask off the exons of all human reference ABC trans-
porter genes. For this, a list of the reference nucleotide
sequence accession numbers of all human ABC transport-
ers was used to retrieve the exon coordinates of the human
protein coding ABC transporter genes from the Table
Browser application of the UCSC Genome Browser [34].
A Perl script was designed to extract and reformat the exon
coordinates from the Table browser output for applica-
tion in the program MaskSeq.
In addition to all human reference ABC transporter
sequences, we downloaded the reference nucleotide
sequences of all known mouse ABC transporters that have
no apparent orthologous counterparts in the human
genome (Abca14, Abca15, Abca16, Abca17, Abcg3). Using a
local installation of the BLAST application (version
2.2.14), a homology search of the reference ABC trans-
porter nucleotide sequences was performed against the
human genome masked for ABC transporter exons. In this
alignment, an E-value of 0.001 and the table output for-
mat "-m8" was applied. To eliminate hits originating from
repetitive sequences, the repetitive sequences in the query
ABC transporter nucleotide sequences were identified by
applying the program RepeatMasker (version 3.1.6) using
the database Repbase (version 11.12). An in-house writ-
ten Perl script was used to exclude all hits that were
located completely within repetitive sequences and those
that extended less than 30 bp into the flanking regions of
repetitive sequences. The remaining hits were then
ordered along the chromosomes and merged to a single
candidate pseudogene when neighbouring hits yielded
highest homology to the same protein coding gene and
when they were in the same 5'→3' orientation as their
homologous ABC transporter nucleotide sequence. In the
absence of a neighbouring hit, a genomic region of 0.1 Mb
flanking the single hit was aligned with the respective ABC
transporter nucleotide sequence using the more rigorous
alignment tool "matcher" from the EMBOSS package.
This approach allows for identification of more distantly
related pseudogenes. Hits displaying > 70% identity over
an entire exon of the respective ABC transporter nucle-
otide sequence, were also considered homologous and
further evaluated. Merged hits were classified as candidate
pseudogenes when (i) the retrieved sequences showed
homologies to at least two exons of a protein coding gene
and (ii) the merged hit contained sequence aberrations
precluding its translation into a functional ABC trans-
porter. Subsequently, all potential pseudogenes were ana-
lyzed using the UCSC Genome Browser [33] to exclude
the possibility that candidate pseudogenes were part of a
known protein coding gene. Additionally, the human
mRNA and EST track of the UCSC Genome Browser were
used to search for transcription of the identified ABC
transporter pseudogenes. A locus was regarded a candi-Page 10 of 13
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gous mRNA or EST sequence exhibited overall > 99% with
the pseudogene but no other sites in the human genome
("best hit").
Sequence similarities and multiple sequence alignments
were calculated using EMBOSS package algorithms
[35,36]. Potential transcription factor binding sites were
identified utilizing tfsearch (version 1.3, threshold score
85.0, classification: vertebrate) [37] and the TRANSFAC
database (release 3.3) [38].
Confirmation of pseudogene transcription
Aliquots of 1 µg pooled total RNA (Human Total RNA
Master Panel II, Clontech) were reverse-transcribed in the
presence of oligo-dT primers in a 20 µl RT reaction using
the Omniscript RT Kit (Qiagen). cDNA was amplified
using the HotStarTaq DNA polymerase Kit (Qiagen). The
cycling conditions were 94°C 30s, 54–60°C 30s and
72°C 30s-3 min followed by a final extension step at
72°C for 10 min. Transcription of pseudogenes was
authenticated utilizing the following primer sets:
ABCA10P 5'-GATTTTGCCAGAGCCTCAGC-3', 5'-GAGT-
GCATTTGCTGCTTGGA-3', ABCA15P2 5'-AACTGGCAT-
GGACCCAGTAG-3', 5'-CTTCCTCCAAAATGCCAAAC-3',
ABCA17P 5'-TCACGCACTGTCTTTCCTTG-3', 5'-CCAGT-
ACAATGGAACTGATGATG-3', ABCC2P 5'-GCCTGGAT-
TCAGAATTGCAT-3', 5'-GCCCCACAAGAAAGCATAAA-3',
ABCC6P1 5'-CCCACGACGACAGAAGG-3', 5'-TTCG-
GAAACCTTGGCTCA-3', ABCC6P2 5'-CCCACGACGACA-
GAAGG-3', 5'-TCTGTTTGGGAGAACCGTGT-3' and
ABCG2P2 5'-GGTACTCCGCTGACACCTTC-3', 5'-TTTCT-
CAACTGGTTTTTGACCA-3'. PCR products were separated
and analyzed on GelStar® (Cambrex) stained 0.8 – 1.5%
agarose gels. Bands of interest were excised and the DNA
was extracted using the QIAquick® Gel Extraction Kit (Qia-
gen). PCR runs resulting in a single band were purified
using Microcon® YM-30 columns (Millipore) for subse-
quent sequence analysis. Purified amplification products
were sequenced as published previously [39]. Sequence
data were analyzed using the program FinchTV v.1.3.1
(Geospiza Inc.) and the UCSC Genome Browser.
Cell culture
HepG2 cells were purchased from ATCC (no. HB-8065)
and cultivated under standard conditions (5% CO2,
37°C) in ATCC complete growth medium (Eagle's
medium) with 2 mM L-glutamine and Earle's BSS (1.5 g/
L sodium bicarbonate, 0.1 mM non-essential amino acids,
1.0 mM sodium pyruvate, 90%; fetal bovine serum, 10%)
containing 2% penicillin/streptomycin.
siRNA mediated knockdown of ABCC6P1 in HepG2 cells
21 mer-siRNAs were designed using the siRNA design tool
from the Whitehead Institute for Biomedical Research
[40], which target the sequence of exon 10 of the pseudo-
gene ABCC6P1. This exon displays no homology
(sequence identity < 20%) with its parental gene ABCC6
and thus allows selective targeting of ABCC6P1. siRNAs
including positive (Silencer GAPDH siRNA) and negative
controls (Silencer Negative Control #1 siRNA) were pur-
chased from Ambion, Inc. After screening of several siR-
NAs, the following siRNAs which yielded the highest
knockdown rates of ABCC6P1 were used in all further
experiments: Sense 5'-CUCCCAGGGAUAUAAAUCAUU-
3', and antisense 5'- UGAUUUAUAUCCCUGGGAGUU-
3', respectively. HepG2 cells were reverse-transfected
using 1.5 µl siRNA (20 µM) complexed with 3 µl siPORT™
NeoFX™ transfection agent (Ambion) in 100 µl OPTI-
MEM buffer (Invitrogen). After 10 min incubation, the
siRNA/lipid-complex was mixed with 900 µl of 105cells/
ml HepG2 cells in culture medium and plated in 12 well
plates. After 24 h incubation under standard conditions
the cells were lysed, RNA was extracted (MagNA Pure LC
RNA Isolation Kit – High Performance, Roche) and quan-
titated on a Nano Drop® spectrophotometer. All siRNA
experiments were performed in duplicate, and the results
of six independent siRNA experiments with ABCC6P1
knockdown rates > 60% were used for statistical analyses.
Quantitative RT-PCR
For gene expression profiling of ABCC6 and ABCC6P1 in
different human tissues, 1 µg total RNA from each tissue
type of Clontech's Human Total RNA Master Panel II, and
for quantitation of transcription levels in the siRNA exper-
iments, 150–250 ng total RNA from HepG2 cells were
reverse transcribed using Omniscript (Qiagen) and oligo-
dT primers. For quantitation of the transcription levels of
selected genes real-time PCR was performed on a 7900HT
Fast Real-Time PCR System (Applied Biosystems) using
standard conditions. The following TaqMan-primer/
probes (Applied Biosystems) were used: ABCC6P1
(designed by Applied Biosystems): forward primer 5'-
CCATCACTGGCCTGGTGTA-3', reverse primer 5'-CTC-
CTGCTGAAATCATCTGAGATTAGT-3', FAM-reporter
probe 5'-CTGTGGATGCCTTTCTG-3' (targeting exon
boundary 9/10 of ABCC6P1), ABCC6 (Assay-ID:
Hs01081199_m1, targeting exon boundary 25/26 of
ABCC6), cyclophilin B (PPIB) (Assay-ID:
Hs00168719_m1), β-actin (ACTB) (Assay-ID:
Hs99999903_m1), GAPDH (Assay-ID:
Hs99999905_m1). All RT-PCR experiments were per-
formed at least in duplicate.
Statistic analyses and calculation of gene/pseudogene 
expression levels
Relative transcript levels were calculated using the ∆∆-ct
method for the two housekeeping genes β-actin and cyclo-
philin B. Means, p-values and confidence intervals were
calculated using the software package SPSS.Page 11 of 13
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